Research Areas

A Phase III Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of An Investigational Medication in Patients with Type 2 Diabetes Mellitus who have Inadequate Glycemic Control on Combination Therapy with Metformin and a PPARγ Agonist

The Durabilitly of Twice-Daily Insulin Lispro Low Mixture Compared to Once-Daily Insulin Glargine when added to Existing Oral Therapy in Patients with Type 2 Diabetes and Inadequate Glycemic Control

Effect and Action in Diabetes of an Investigational Medication Effect on Glycemic Control of An Investigational Medication versus Glimepiride in Type 2 Diabetes. A Fifty-Two Week (with Fifty-Two Week Open-Label Extension), Double-Blinded, Multicenter, Randomized, Parallel Study to Investigate Safety and Efficacy

A Pilot Study of the Efficacy and Safety of an Investigational Medication on Glycemic Control in Subjects with Type 2 Diabetes Treated Aggressively but not Controlled on CombinationAntihyperglycemic Therapy with Metformin and/or Thiazolidinedione (TZD) and Insulin

A Prospective, Multicenter, Open-Label, Randomized, Controlled Clinical Trial Comparing the Efficacy and Safety in Subjects with Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of An Investigational Insulin Vs. Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 24-Week Follow Up

Collection of blood and urine samples in males 18-30-years old

Collection of normal blood sample for use in genetic studies for Lung Cancer

A Phase II Randomized, Placebo-Controlled Dose-Ranging Trial of an Investigational Medication in Diabetic Patients with Painful Peripheral Neuropathy

A Multicenter, Randomized, Double-Blind, Amlodipine and Placebo-Controlled, 10 Week Study of an Investigational Medication in the Treatment of Mild to Moderate Hypertension

An Open-Label, Community-Based Clinical Practice Study of Niaspan in Patients with Hyperlipidemia

A Multicenter, Open-Label Study Evaluating the Safety and Tolerability of Tramadol Hydrochloride Controlled-Release Tablets in Patients With Chronic Pain

A Phase II Double-Blind, Placebo-Controlled, Randomized Efficacy Study of an Investigational Medication in Patients Undergoing Direct Percutaneous Transluminar Coronary Angioplasty Following Acute Myocardial Infarction

A Randomized, Double-Blind, Placebo-Controlled, Six-Month Safety and Efficacy Trial of an Investigational Medication in Type II Diabetes Mellitus Patients

A 26 week Randomized, Double-Blind, Multicenter, Study to Evaluate the Safety, Efficacy, and Tolerability of an Investigational Medication when Administered to Patients with Type II Diabetes Mellitus Patients Who are Inadequately Controlled on Insulin Monotherapy

A 26-Week Randomized, Double Blind, Double-Dummy, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of an Investigational Medication When Administered to Patients with Type II Diabetes Mellitus Who are Inadequately Controlled on a Maintenance Dose of Metformin

A 26 Week, Randomized, Double-Blind, Multicenter, Placebo Controlled Study to Evaluate the Safety, Efficacy, and Tolerability of an Investigational Medication When Administered to Type II Diabetes Mellitus Using a Once Daily Dosing Regimen, and to Determine the Therapeutic Equivalence of the Once and Twice Daily Dosing Regimens

A Double-Blind, Placebo Controlled, Randomized Study of the Safety and Efficacy of a Combination of Metformin and an Investigational Medication in the Treatment of Type II Diabetes Mellitus Patients

A Double-Blind, Placebo Controlled, Randomized Study of the Safety and Efficacy of a Combination of Sulfonylurea and Two Doses of an Investigational Medication in the Treatment of Type II Diabetes Mellitus Patients

A Double-Blind, Placebo Controlled, Randomized Study of the Safety and Efficacy of a Combination of Insulin and Two Doses of an Investigational Medication in the Treatment Of Type II Diabetes Mellitus Patients

A Multi-Center, Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of An Investigational Medication in Patients With Type 2 Diabetes Mellitus